Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

137.12 +0.82 (+0.60%)
Streaming Delayed Price Updated: 12:56 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021. 
Via Benzinga
10 Biggest Price Target Changes For Friday
Piper Sandler boosted Accenture plc (NYSE:ACN) pric... 
Via Benzinga
7 Meme Stocks to Buy on Their Market Slump and Rebound
These seven meme stocks suffered downturns recently, but they have the appropriate catalysts to move upward in the near term. 
Via InvestorPlace
Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack
Photo by Michael Longmire on... 
Via Benzinga
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash... 
Via Talk Markets
Topics Cannabis
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
Pharmaceutical giant Pfizer Inc. (NYSE:PFE) is e... 
Via Benzinga
Topics Cannabis
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) revealed initial positive results from a Phase 2/3 trial of intramuscular (IM) administration of Rylaze (asparaginase... 
Via Benzinga
Jupiter Wellness Just Reported A Big Move In Pharma
Image provided by Jupiter Wellness of their new lab. The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content... 
Via Benzinga
3 High-Growth Stocks That Are Screaming Buys in December
Now is a good time to be greedy and buy up these depressed stocks. 
Via The Motley Fool
Got $5,000? Buy These 3 Hot Pot Stocks Immediately
There might not be a better time to buy these three cannabis stocks than right now. 
Via The Motley Fool
Topics Cannabis
EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru
Cannabis-based drug Sativyl has been approved as a treatment for cancer-related pain in Peru. 
Via Benzinga
2 Top Marijuana Stocks to Buy for the Long Haul
If you're patient with these investments, they can produce great returns for your portfolio. 
Via The Motley Fool
Topics Cannabis
Better Buy: Compass Pathways vs. Jazz Pharmaceuticals
Both of these biotech stocks are innovators, but one is more likely to hit it out of the park. 
Via The Motley Fool
The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign
Below is a recap of the main news related to the cannabis industry and markets for the week of November 8, 2021. 
Via Benzinga
Topics Cannabis
7 F-Rated Stocks to Sell Before We Reach Christmas
It's just as important to know what stocks to sell as it is to know what stocks to buy. These stocks are prime examples of stocks to drop now. 
Via InvestorPlace
Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Call Transcript
JAZZ earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance
Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharma... 
Via Benzinga
Jazz Pharmaceuticals: Q3 Earnings Insights
Jazz Pharmaceuticals (NASDAQ: JAZZ) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... 
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
Lexaria Bioscience Corp (NASDAQ: LEXX) has commenced a new study to compare the effectiveness of Epidiolex to DehydraTECH-cannabidiol (CBD) for reducing seizure... 
Via Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
2 Top Growth Stocks to Buy Heading Into November
There's plenty of growth on the horizon for these stocks, which are trading near their lows for the year. 
Via The Motley Fool
Jim Cramer Considers nCino As Winner, Prefers This Stock Over Perficient
On CNBC’s "Mad Money ... 
Via Benzinga
Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause
Photo by MART PRODUCTION from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
SEC Charges Former Goldman Sachs Officer For Insider Trading On 2 M&A Deals
The Securities and Exchange Commission has charged a former Goldman Sachs (NYSE: GS) compliance analyst with using confidential information to generate over $... 
Via Benzinga
Topics Regulatory Compliance
Needham Initiates Coverage With Buy For This Narcolepsy Player
Needham 
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ: 
Via Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.